Ebn Sina Medical

What Ebn Sina Medical does

Ebn Sina Medical W.L.L. is a Doha-based pharmaceutical and healthcare distribution company founded in 1971 as a single retail pharmacy and now operating as a wholly-owned subsidiary of Aamal Company Q.P.S.C. (Qatar Exchange-listed, founded by Sheikh Faisal Bin Qassim Al Thani). The company distributes pharmaceuticals, medical equipment, hospital sundries, dental and diagnostic products, and consumer health/cosmetics through exclusive agreements with 60+ global partners including Abbott, Roche, Novartis, Pfizer, Novo Nordisk, GSK, AstraZeneca, B. Braun, Boston Scientific, and Stryker, managing 3,400+ SKUs across an integrated warehouse and retail network.

The company serves three primary channels: (1) B2B wholesale distribution to government entities (Hamad Medical Corporation, Ministry of Public Health, Primary Health Care), semi-government institutions (Sidra Medicine, Aspetar, Qatar Diabetes Association, Qatar Red Crescent), and private hospitals and pharmacies; (2) a direct-to-consumer retail pharmacy network of 4 Ebn Sina Pharmacy locations across Doha (City Center, Ras Abo Aboud, Msheirib Metro Station, Downtown); and (3) 3 specialty Foot Care Centres (City Center, Lulu Gharaffa, The Pearl) offering podiatry-adjacent services. Its operational backbone includes the largest pharmaceutical warehouses in Qatar, RIEDL Phasys pharmacy automation, ISO 9001:2000 quality management certification, and a documented delivery time of under 36 hours, supporting a reported near-50% share of Qatar's pharmaceutical sector.

Revenue mechanics are primarily transaction-based distribution markups on pharmaceutical and medical equipment sales, supplemented by retail pharmacy and foot care service revenue. Customer concentration is structurally high around anchor government healthcare accounts, with 450+ named customers across the institutional and retail base. The company co-hosts regional healthcare events such as the ACT Summit with Novo Nordisk Qatar, and continues to expand its therapeutics portfolio (e.g., Semaglutide 2.4 mg launch in October 2025), reinforcing its position as Qatar's default pharmaceutical distribution platform.

Name

Ebn Sina Medical

Legal name

Ebn Sina Medical W.L.L.

Website

https://ebnsina.com/

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

101–250 employees

Short description

Ebn Sina Medical is a Doha-based pharmaceutical and healthcare distribution company, founded in 1971 and a subsidiary of Aamal Company. It distributes pharmaceuticals and medical equipment from 60+ global brands to government, semi-government, and private healthcare customers in Qatar, and operates a retail pharmacy and foot care network.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)

akta.pro secondary industry

Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)

Keywords

• Pharmaceutical distribution
• Healthcare supply chain
• Retail pharmacy services
• Medical equipment supply
• Consumer foot care

Headquarters

HQ city

Doha

HQ country

Qatar

HQ region

Middle East

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Ebn Sina Medical distributes pharmaceuticals, medical equipment, hospital sundries, dental products, and diagnostic equipment to government, semi-government and private healthcare sectors through exclusive distribution agreements with global pharmaceutical companies.
2. Retail Pharmacy Operations: Ebn Sina Medical operates a network of 4 pharmacies and 3 foot care centers in prime Doha locations, serving end-consumers directly with pharmaceuticals and healthcare products.
3. Consumer Health & OTC Products: Distribution and marketing of consumer health products, OTC medications, skin care, hair care, footcare and medicated cosmetics.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels3 records

Core offering

Ebn Sina Medical is a pharmaceutical and healthcare distribution company that supplies medicines, medical equipment, and consumer health products to government, semi-government, and private healthcare institutions across Qatar. In addition to its wholesale distribution business, the company operates retail pharmacies and foot care centers that serve individual consumers directly.

Product overview

Ebn Sina Medical operates as a pharmaceutical distribution and healthcare services company in Qatar. The company offers a multi-faceted portfolio comprising: (1) a retail pharmacy network with four Ebn Sina Pharmacy locations across Doha, (2) three Foot Care Center locations offering specialized foot and hand care services, (3) RIEDL Phasys pharmacy automation systems for pharmacies and warehouses, and (4) comprehensive pharmaceutical and medical equipment distribution services. The company serves government, semi-government, and private healthcare sectors through exclusive distribution agreements with over 60 global pharmaceutical partners, managing approximately 3,400 SKUs.

Differentiator

Problem solved

Functional benefit

Brands

• Ebn Sina Pharmacies: Network of pharmacies managed by Ebn Sina Medical located in prime locations across Doha, Qatar
• Foot Care Centres

Quantifiable outcome

• Close to 50% market share in Qatar pharmaceutical sector
• +4 more outcomes

Named customers8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

24 partnerships are on record, tiered core, flagship and minor.

• AbbottcoreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company with exclusive distribution agreement for pharmaceutical products in Qatar through Ebn Sina Medical's distribution network
• RochecoreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical and diagnostics company with distribution partnership through Ebn Sina Medical in Qatar
• NovartiscoreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company with exclusive distribution agreement in Qatar through Ebn Sina Medical
• PfizercoreChannel Partner/ Reseller/ DistributorMajor global pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• Novo NordiskflagshipStrategic or Co-development PartnerGlobal pharmaceutical company specializing in diabetes and obesity treatments. Ebn Sina Medical collaborated to host the ACT Summit in Qatar, bringing together 350+ healthcare professionals from 12+ countries. Ebn Sina Medical serves as distributor for Novo Nordisk products including Semaglutide 2.4mg launched in Qatar.
• GSK (GlaxoSmithKline)coreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• SanoficoreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company with distribution agreement through Ebn Sina Medical in Qatar
• Janssen (Johnson & Johnson)coreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• AlconcoreChannel Partner/ Reseller/ DistributorGlobal eye care company with distribution partnership through Ebn Sina Medical in Qatar
• AstraZenecacoreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company with distribution agreement through Ebn Sina Medical in Qatar
• Sandoz (Novartis Division)coreChannel Partner/ Reseller/ DistributorGeneric pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• ServiercoreChannel Partner/ Reseller/ DistributorGlobal independent pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• B. BrauncoreChannel Partner/ Reseller/ DistributorGlobal medical technology company with distribution partnership through Ebn Sina Medical in Qatar
• Boston ScientificcoreChannel Partner/ Reseller/ DistributorGlobal medical device company with distribution partnership through Ebn Sina Medical in Qatar
• StrykercoreChannel Partner/ Reseller/ DistributorGlobal medical technology company with distribution partnership through Ebn Sina Medical in Qatar
• BeiGeneminorChannel Partner/ Reseller/ DistributorGlobal oncology company with distribution partnership through Ebn Sina Medical in Qatar
• LundbeckminorChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company focused on brain diseases with distribution partnership in Qatar
• EvaPharmacoreChannel Partner/ Reseller/ DistributorRegional pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• HikmacoreChannel Partner/ Reseller/ DistributorMultinational pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• ViatriscoreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company formed by merger with distribution partnership through Ebn Sina Medical in Qatar
• StadaminorChannel Partner/ Reseller/ DistributorGerman pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• ChiesiminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical company with distribution partnership through Ebn Sina Medical in Qatar
• AccurayminorChannel Partner/ Reseller/ DistributorGlobal radiation oncology company with distribution partnership through Ebn Sina Medical in Qatar
• Aamal Company Q.P.S.C.flagshipOthersEbn Sina Medical is a wholly-owned subsidiary of Aamal Company Q.P.S.C., a publicly traded company on Qatar Exchange with paid-up capital of QAR 6 billion. Aamal is one of Qatar's largest diversified companies, formed in 2001 and listed in 2007. Sheikh Faisal Bin Qassim Al Thani is the Chairman.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Qatar Pharma: Qatar Pharma is one of the main local pharmaceutical distributors in Doha, directly competing with Ebn Sina Medical for exclusive distribution agreements with global pharma manufacturers and for supply contracts with Hamad Medical Corporation and private healthcare providers in Qatar.
• Ebrahim Al Neama & Co. (EAN): Ebrahim Al Neama & Co. is an established Qatari pharmaceutical and healthcare distributor that competes with Ebn Sina Medical across government hospital supply, private pharmacy resupply, and consumer health distribution channels within the same Qatar-only TAM.
• Al Hekma Medical Services: Al Hekma is a Qatar-based medical and pharmaceutical distributor serving hospitals and clinics in Doha; it competes directly with Ebn Sina Medical for the same institutional customers and global supplier mandates within the Qatar healthcare market.

Regional players

• Julphar (Gulf Pharmaceutical Industries): Julphar is a UAE-based pharmaceutical manufacturer and GCC-wide distributor with a regional distribution network across MENA; it overlaps with Ebn Sina's distribution business in Gulf markets and competes for manufacturer mandates from the same tier-1 global pharma companies.
• SPIMACO Addwaeih: SPIMACO is a leading Saudi pharmaceutical manufacturer and distributor with established GCC distribution capabilities; it represents the kind of regional scale player that global pharma majors compare against Ebn Sina Medical when awarding multi-country distribution mandates in MENA.
• Ali Abdulwahab Al Mutawa (AAW): AAW is a major Kuwait-headquartered healthcare and consumer goods distributor with exclusive partnerships across global pharma and FMCG brands; it operates a comparable distributor model in an adjacent GCC market and is a relevant peer for benchmarking MENA distribution economics.
• Tabuk Pharmaceuticals: Tabuk is one of Saudi Arabia's largest pharmaceutical manufacturers with growing GCC and MENA distribution; it competes with Ebn Sina Medical for global pharma licensing deals and provides a relevant regional benchmark for branded generics and distribution scale.
• Dallah Healthcare Holding: Dallah is a leading Saudi healthcare services and pharmaceutical distribution group operating hospitals, clinics and pharmacy supply across the Kingdom; it is a comparable diversified healthcare conglomerate with adjacent distribution scale and an instructive benchmark for Gulf-region expansion.

Broad incumbents

• Hikma Pharmaceuticals: Hikma is a leading MENA-headquartered pharmaceutical company with both branded, generic and injectable manufacturing plus regional distribution; it is both an Ebn Sina partner and a broad incumbent whose distribution arm overlaps with Ebn Sina's across multiple Gulf markets.
• McKesson Corporation: McKesson is the world's largest pharmaceutical distributor and a clear reference point for the B2B pharma distribution model Ebn Sina operates at national level; it represents the global best-in-class benchmark for logistics, automation and pharmaceutical supply chain operations.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ebn Sina Medical